Cited by 962Antimicrobial Resistance in StaphylococcusAntibiotic Resistance in BacteriaAntibiotic Use and Resistance

The DOI matches its Crossref record; 405 of the 406 references it cites were found in a registry or an index.

Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

Open access

Howden, Benjamin P., Davies, John K., Johnson, Paul D. R., Stinear, Timothy P., Grayson, M. Lindsay·2010·Clinical Microbiology Reviews

DOI 10.1128/cmr.00042-09PMC PMC2806658

Open this paper in CoChat — free account

Abstract

SUMMARY: The emergence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) over the past decade has provided a challenge to diagnostic microbiologists to detect these strains, clinicians treating patients with infections due to these strains, and researchers attempting to understand the resistance mechanisms. Recent data show that these strains have been detected globally and in many cases are associated with glycopeptide treatment failure; however, more rigorous clinical studies are required to clearly define the contribution of hVISA to glycopeptide treatment outcomes. It is now becoming clear that sequential point mutations in key global regulatory genes contribute to the hVISA and VISA phenotypes, which are associated predominately with cell wall thickening and restricted vancomycin access to its site of activity in the division septum; however, the phenotypic features of these strains can vary because the mutations leading to resistance can vary. Interestingly, changes in the staphylococcal surface and expression of agr are likely to impact host-pathogen interactions in hVISA and VISA infections. Given the subtleties of vancomycin susceptibility testing against S. aureus , it is imperative that diagnostic laboratories use well-standardized methods and have a framework for detecting reduced vancomycin susceptibility in S. aureus .

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/cmr.00042-09

Cites

405 of 405 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,018
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Osteomyelitis
Lew, D. P., & Waldvogel, F. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16727-5 · Cited by 1,988
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
Community-Acquired Methicillin-ResistantStaphylococcus aureusCarrying Panton-Valentine Leukocidin Genes: Worldwide Emergence
Vandenesch, F., Naimi, T. S., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M. E., et al. (2003) · Emerging infectious diseases · doi:10.3201/eid0908.030089 · Cited by 1,718
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
The Changing Epidemiology of Staphylococcus aureus ?
Chambers, H. F. “. (2001) · Emerging infectious diseases · doi:10.3201/eid0702.010204 · Cited by 1,419
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,411
Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999
Diekema, D. J., Pfaller, M. A., Schmitz, F., Smayevsky, J., Bell, J. M., Jones, R. N., Beach, M. L., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,363

Show all 406 references

Research works printed but not linked: 1

Ferraz, V., A. G. Duse, M. Kassel, A. D. Black, T. Ito, and K. Hiramatsu. 2000. Vancomycin-resistant Staphylococcus aureus occurs in South Africa. S. Afr. Med. J.90:1113.

Sorted by citations

Items 301–400 of 962

Structure and antibacterial activities of new cyclic peptide antibiotics, pargamicins B, C and D, from Amycolatopsis sp. ML1-hF4
Hashizume, H., Sawa, R., Yamashita, K., Nishimura, Y., & Igarashi, M. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.34 · Cited by 33
Identification of tigecycline- and vancomycin-resistant Staphylococcus aureus strains among patients with urinary tract infection in Iran
Yousefi, M., Fallah, F., Arshadi, M., Pourmand, M. R., Hashemi, A., & Pourmand, G. (2017) · New Microbes and New Infections · doi:10.1016/j.nmni.2017.05.009 · Cited by 33
In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents
Díaz, M. C. L., Ríos, E., Rodríguez-Avial, I., Simaluiza, R. J., Picazo, J. J., & Culebras, E. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.01.039 · Cited by 33
Total Synthesis of Tetarimycin A, (±)-Naphthacemycin A 9 , and (±)-Fasamycin A: Structure–Activity Relationship Studies against Drug-Resistant Bacteria
Huang, J., Lauderdale, T.-L. Y., Lin, C., & Shia, K. (2018) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.8b00802 · Cited by 33
Decreased susceptibility of Streptococcus anginosus to vancomycin in a multispecies biofilm is due to increased thickness of the cell wall
Tavernier, S., Sass, A. M., Bruyne, M. D., Baeke, F., Rycke, R. M. D., Crabbé, A., Vandecandelaere, I., Nieuwerburgh, F. V., & Coenye, T. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky216 · Cited by 32
YjbH regulates virulence genes expression and oxidative stress resistance in Staphylococcus aureus
Paudel, A., Panthee, S., Hamamoto, H., Grunert, T., & Sekimizu, K. (2021) · Virulence · doi:10.1080/21505594.2021.1875683 · Cited by 33
Antibacterial Small Molecules That Potently Inhibit Staphylococcus aureus Lipoteichoic Acid Biosynthesis
Naclerio, G. A., Karanja, C. W., Opoku‐Temeng, C., & Sintim, H. O. (2019) · ChemMedChem · doi:10.1002/cmdc.201900053 · Cited by 32
Molecular analysis, biofilm formation, and susceptibility of methicillin-resistant Staphylococcus aureus strains causing community- and health care-associated infections in central venous catheters
Sohail, M. L., & Latif, Z. (2018) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0373-2017 · Cited by 32
Methicillin-Resistant Staphylococcus aureus (MRSA): Prevalence, Antimicrobial Susceptibility Pattern, and Detection of mec A Gene among Cardiac Patients from a Tertiary Care Heart Center in Kathmandu, Nepal
Dhungel, S., Rijal, K. R., Yadav, B., Dhungel, B., Adhikari, N., Shrestha, U. T., Adhikari, B., Banjara, M. R., & Ghimire, P. (2021) · Infectious Diseases Research and Treatment · doi:10.1177/11786337211037355 · Cited by 34
A rapid in situ procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis
Santiso, R., Tamayo, M., Gosálvez, J., Bou, G., Fernández, M. D. C., & Fernández, J. L. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-191 · Cited by 32
Role of sortase A in the pathogenesis ofStaphylococcus aureus-induced mastitis in mice
Chen, F., Liu, B., Wang, D., Wang, L., Deng, X., Bi, C., Xiong, Y., Wu, Q., Cui, Y., Zhang, Y., et al. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12354 · Cited by 32
Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis
Ishii, K., Tabuchi, F., Matsuo, M., Tatsuno, K., Sato, T., Okazaki, M., Hamamoto, H., Matsumoto, Y., Kaito, C., Aoyagi, T., et al. (2015) · Scientific Reports · doi:10.1038/srep17092 · Cited by 33
Clinical, Microbiological, and Genetic Characteristics of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia in a Teaching Hospital
Gregorio, S. D., Perazzi, B. E., Ordoñez, A. M., de Gregorio, S., Foccoli, M., Lasala, M. B., García, S. D., Vay, C. A., Famiglietti, A. M. R., & Mollerach, M. E. (2014) · Microbial Drug Resistance · doi:10.1089/mdr.2014.0190 · Cited by 31
A network meta-analysis of antibiotics for treatment of hospitalised patients with suspected or proven meticillin-resistant Staphylococcus aureus infection
Bally, M., Dendukuri, N., Sinclair, A., Ahern, S. P., Poisson, M., & Brophy, J. M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.08.004 · Cited by 29
Early agr activation correlates with vancomycin treatment failure in multi-clonotype MRSA endovascular infections
Abdelhady, W., Chen, L., Bayer, A. S., Seidl, K., Yeaman, M. R., Kreiswirth, B. N., & Xiong, Y. Q. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku547 · Cited by 31
The frontline antibiotic vancomycin induces a zinc starvation response in bacteria by binding to Zn(II)
Zarkan, A., Macklyne, H.-R., Truman, A. W., Hesketh, A. R., & Hong, H. (2016) · Scientific Reports · doi:10.1038/srep19602 · Cited by 32
In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model
Lepak, A. J., Parhi, A. K., Madison, M., Marchillo, K., VanHecker, J., & Andes, D. R. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01464-15 · Cited by 31
Real-world performance of a microarray-based rapid diagnostic for Gram-positive bloodstream infections and potential utility for antimicrobial stewardship
Aitken, S. L., Hemmige, V. S., Koo, H. L., Vuong, N. N., Lasco, T. M., & Garey, K. W. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.09.025 · Cited by 30
Novel pyridyl nitrofuranyl isoxazolines show antibacterial activity against multiple drug resistant Staphylococcus species
Picconi, P., Prabaharan, P., Auer, J. L., Sandiford, S. K., Cascio, F., Chowdhury, M. M., Hind, C. K., Wand, M. E., Sutton, J. M., & Rahman, K. M. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.05.037 · Cited by 30
Rapid and easy detection of low-level resistance to vancomycin in methicillin-resistant Staphylococcus aureus by matrix-assisted laser desorption ionization time-of-flight mass spectrometry
Asakura, K., Azechi, T., Sasano, H., Matsui, H., Hanaki, H., Miyazaki, M., Takata, T., Sekine, M., Takaku, T., Ochiai, T., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194212 · Cited by 30
Artocarpus integrifolia seed lectin enhances membrane damage, oxidative stress and biofilm inhibition activity of silver nanoparticles against Staphylococcus aureus
Subramaniyan, S. B., Megarajan, S., Singaravelu, D. K., & Veerappan, A. (2021) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2021.126842 · Cited by 30
Molecular Confirmation of Vancomycin-Resistant Staphylococcus aureus with vanA Gene from a Hospital in Kathmandu
Maharjan, M., Sah, A. K., Pyakurel, S., Thapa, S., Maharjan, S., Adhikari, N., Rijal, K. R., Ghimire, P., & Shrestha, U. T. (2021) · International Journal of Microbiology · doi:10.1155/2021/3847347 · Cited by 30
Vancomycin-modified nitrogen and chloride doped carbon dots and their application as a Staphylococcus aureus probe
Tabaraki, R., & Nazari, F. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.341311 · Cited by 30
High-Dose Daptomycin Therapy for Staphylococcal Endocarditis and When to Apply It
Smith, J. R., Claeys, K. C., Barber, K. E., & Rybak, M. J. (2014) · Current Infectious Disease Reports · doi:10.1007/s11908-014-0429-6 · Cited by 30
Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing
Chen, C., Lin, M., Shu, J., & Lu, J. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt395 · Cited by 30
Precision of Vancomycin and Daptomycin MICs for Methicillin-Resistant Staphylococcus aureus and Effect of Subculture and Storage
Charlton, C. L., Hindler, J. A., Turnidge, J. D., & Humphries, R. M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01571-14 · Cited by 30
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types
Farrell, D. J., Flamm, R. K., Sader, H. S., & Jones, R. N. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.11.005 · Cited by 30
Digital antimicrobial susceptibility testing using the MilliDrop technology
Jiang, L., Boitard, L., Broyer, P., Chareire, A.-C., Bourne-Branchu, P., Mahé, P., Tournoud, M., Franceschi, C., Zambardi, G., Baudry, J., et al. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2554-z · Cited by 30
Single-Molecule Sequencing (PacBio) of the Staphylococcus capitis NRCS-A Clone Reveals the Basis of Multidrug Resistance and Adaptation to the Neonatal Intensive Care Unit Environment
Martins-Simões, P., Lemriss, H., Dumont, Y., Lemriss, S., Rasigade, J., Trouillet‐Assant, S., Ibrahimi, A., Kabbaj, S. E., Butin, M., & Laurent, F. J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01991 · Cited by 30
Clinical, Epidemiologic, and Laboratory Aspects of Methicillin-Resistant Staphylococcus aureus Infections
Palavecino, E. L. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-664-1_1 · Cited by 31
Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus
Amberpet, R., Sistla, S., Sugumar, M., Nagasundaram, N., Manoharan, M., & Parija, S. (2019) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1976_17 · Cited by 29
Synergy of Linezolid with Several Antimicrobial Agents against Linezolid-Methicillin-Resistant Staphylococcal Strains
Valderrama, M. J., Alfaro, M., Rodríguez-Avial, I., Baos, E., Rodríguez-Avial, C., & Culebras, E. (2020) · Antibiotics · doi:10.3390/antibiotics9080496 · Cited by 29
Andrographolide Sulfonate Is a Promising Treatment to Combat Methicillin-resistant Staphylococcus aureus and Its Biofilms
Zhang, L., Wen, B., Bao, M., Cheng, Y., Mahmood, T., Yang, W., Chen, Q., Lv, L., Li, L., Yi, J., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.720685 · Cited by 29
Adaptive laboratory evolution and independent component analysis disentangle complex vancomycin adaptation trajectories
Fait, A., Seif, Y., Mikkelsen, K., Poudel, S., Wells, J. M., Palsson, B. Ø., & Ingmer, H. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118262119 · Cited by 29
Relationships between vancomycin minimum inhibitory concentration, dosing strategies, and outcomes in methicillin-resistant Staphylococcus aureus bacteremia
Clemens, E. C., Chan, J. D., Lynch, J. B., & Dellit, T. H. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.08.002 · Cited by 29
In vivo efficacy and synergistic interaction of 16α-hydroxycleroda-3, 13 (14) Z-dien-15, 16-olide, a clerodane diterpene from Polyalthia longifolia against methicillin-resistant Staphylococcus aureus
Gupta, V. K., Verma, S., Pal, A., Srivastava, S. K., Srivastava, P. K., & Darokar, M. P. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5154-9 · Cited by 29
Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals
Tenover, F. C., Tickler, I. A., Armstrong, E. S., Kubo, A., López, S., Persing, D. H., & Miller, G. H. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.05.016 · Cited by 29
The ATTAIN Trials: Efficacy and Safety of Telavancin Compared with Vancomycin for the Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
Barriere, S. L. (2014) · Future Microbiology · doi:10.2217/fmb.14.4 · Cited by 29
Adaptation to vancomycin pressure of multiresistantStaphylococcus capitisNRCS-A involved in neonatal sepsis
Butin, M., Martins-Simões, P., Picaud, J., Kearns, A., Claris, O., Vandenesch, F., Laurent, F. J., & Rasigade, J. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv217 · Cited by 29
Mechanisms of Antibacterial Resistance
Rossolini, G. M., Arena, F., & Giani, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00138-6 · Cited by 31
Characterization of Staphylococcus aureus Primosomal DnaD Protein: Highly Conserved C-Terminal Region Is Crucial for ssDNA and PriA Helicase Binding but Not for DnaA Protein-Binding and Self-Tetramerization
Huang, Y., Lien, Y., Huang, C., & Huang, C.-Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157593 · Cited by 26
Synergistic Potential of Antimicrobial Combinations Against Methicillin-Resistant Staphylococcus aureus
Yu, Y., Huang, H.-L., Ye, X.-Q., Cai, D.-T., Fang, J.-T., Sun, J. G., Liao, X., & Liu, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01919 · Cited by 28
Mechanisms and impact of antimicrobial resistance in Clostridioides difficile
Dureja, C., Olaitan, A. O., & Hurdle, J. G. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.01.004 · Cited by 28
Potent in vitro synergism of fusidic acid (FA) and berberine chloride (BBR) against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)
Liang, R., Yong, X., Duan, Y.-Q., Tan, Y., Zeng, P., Zhou, Z., Jiang, Y., Wang, S., Jiang, Y.-P., Huang, X., et al. (2014) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-014-1712-2 · Cited by 27
Decreasing incidence of Staphylococcus aureus bacteremia over 9 years: Greatest decline in community-associated methicillin-susceptible and hospital-acquired methicillin-resistant isolates
Khatib, R., Sharma, M., Iyer, S. P., Fakih, M. G., Obeid, K. M., Venugopal, A. A., Fishbain, J. T., Johnson, L. B., Segireddy, M., Jose, J., et al. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2012.03.038 · Cited by 27
Promoter-Specific Transcription Inhibition in Staphylococcus aureus by a Phage Protein
Osmundson, J., Diez, C. M., Westblade, L. F., Hochschild, A., & Darst, S. A. (2012) · Cell · doi:10.1016/j.cell.2012.10.034 · Cited by 28
Encouraging rational antibiotic use in childhood pneumonia: a focus on Vietnam and the Western Pacific Region
Phuong, N. T. K., Hoang, T. T., Vân, P. H., Tu, L., Graham, S. M., & Marais, B. J. (2017) · Pneumonia · doi:10.1186/s41479-017-0031-4 · Cited by 28
Endophthalmitis caused by gram-positive bacteria resistant to vancomycin: Clinical settings, causative organisms, antimicrobial susceptibilities, and treatment outcomes
Hegde, S., Relhan, N., Pathengay, A., Mohan, N., & Flynn, H. W. (2018) · American Journal of Ophthalmology Case Reports · doi:10.1016/j.ajoc.2018.02.030 · Cited by 28
Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile
Henson, K. E. R., Levine, M. T., Wong, E. A. H., & Levine, D. P. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1068118 · Cited by 28
Which antibiotic for resistant Gram-positives, and why?
Bradley, J. S. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.016 · Cited by 28
Semisynthetic guanidino lipoglycopeptides with potent in vitro and in vivo antibacterial activity
van Groesen, E., Mons, E., Kotsogianni, I., Arts, M., Tehrani, K. H. M. E., Wade, N., Lysenko, V., Stel, F., Zwerus, J. T., Benedetti, S. D., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.abo4736 · Cited by 27
Comparative in vitro activity of telavancin, vancomycin and linezolid against heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA)
Leonard, S. N., Szeto, Y. G., Zolotarev, M., & Grigoryan, I. V. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.02.007 · Cited by 27
Occurrence of vancomycin-resistant Staphylococcus aureus in the oral cavity of patients with dental caries
Vellappally, S., Divakar, D. D., Kheraif, A. A. A., Ramakrishnaiah, R., Alqahtani, A., Dalati, M. H. N., Anil, S., Khan, A. A., & Varma, P. R. H. (2017) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.64.2017.033 · Cited by 27
Rational Design and Synthesis of Modified Teixobactin Analogues: In Vitro Antibacterial Activity against Staphylococcus aureus, Propionibacterium acnes and Pseudomonas aeruginosa
Ng, V., Kuehne, S. A., & Chan, W. C. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201801423 · Cited by 27
Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Staphylococcus aureus in a Simulated Pharmacodynamic/Pharmacokinetic Model
Kebriaei, R., Rice, S., Stamper, K. C., & Rybak, M. J. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01743-18 · Cited by 27
The combined antibacterial effects of sodium new houttuyfonate and berberine chloride against growing and persistent methicillin-resistant and vancomycin-intermediate Staphylococcus aureus
Li, X., Wang, P., Hu, X., Zhang, Y., Lü, X., Li, C., Nie, T., Li, G., Wang, X., Pang, J., et al. (2020) · BMC Microbiology · doi:10.1186/s12866-020-02003-2 · Cited by 28
Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents
Bradley, J. S., Flanagan, S. D., Arrieta, A. C., Jacobs, R. F., Capparelli, E. V., & Prokocimer, P. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001096 · Cited by 27
Staphylococcus aureus , a Food Pathogen: Virulence Factors and Antibiotic Resistance
Castro, A., Silva, J., & Teixeira, P. C. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811444-5.00008-7 · Cited by 28
Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics
Nasrin, S., Ganji, S., Kakirde, K. S., Jacob, M. R., Wang, M., Ravu, R. R., Cobine, P. A., Khan, I. A., Wu, C. C., Mead, D. A., et al. (2018) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00903 · Cited by 27
Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey
Sancak, B., Yağcı, S., Gür, D., Gülay, Z., Öğünç, D., Söyletir, G., Yalçın, A. N., Dündar, D., Topçu, A. W., Akşit, F., et al. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-583 · Cited by 26
El catéter periférico: el gran olvidado de la infección nosocomial
Capdevila, J. A. (2013) · Revista española de quimioterapia. Suplemento · Cited by 26
Recent pattern of antibiotic resistance in Staphylococcus aureus clinical isolates in Eastern India and the emergence of reduced susceptibility to vancomycin
Mohanty, S., Behera, B., Sahu, S., & Praharaj, A. K. (2019) · Journal of Laboratory Physicians · doi:10.4103/jlp.jlp_39_19 · Cited by 27
Resistencia a antibióticos de última línea en cocos Gram positivos: la era posterior a la vancomicina
Rincón, S., Panesso, D., Díaz, L., Carvajal, L. P., Reyes, J., Munita, J. M., & Arias, C. A. (2014) · Biomédica · doi:10.7705/biomedica.v34i0.2210 · Cited by 39
Ventilator-associated pneumonia in burn patients: a cause or consequence of critical illness?
Huzar, T. F., & Cross, J. M. (2011) · Expert Review of Respiratory Medicine · doi:10.1586/ers.11.61 · Cited by 27
Simple synthesis of endophenazine G and other phenazines and their evaluation as anti-methicillin-resistant Staphylococcus aureus agents
Udumula, V., Endres, J. L., Harper, C. N., Jaramillo, L., Zhong, H., Bayles, K. W., & Conda‐Sheridan, M. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.079 · Cited by 26
Large-Scale Screening and Identification of Novel Pathogenic Staphylococcus aureus Genes Using a Silkworm Infection Model
Paudel, A., Hamamoto, H., Panthee, S., Matsumoto, Y., & Sekimizu, K. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa004 · Cited by 26
Safety and Efficacy of Nafcillin for Empiric Therapy of Late-Onset Sepsis in the NICU
Magers, J. K., Prusakov, P. A., Speaks, S., Conroy, S., & Sánchez, P. J. (2022) · PEDIATRICS · doi:10.1542/peds.2021-052360 · Cited by 25
Highly Synergistic Effects of Melittin With Vancomycin and Rifampin Against Vancomycin and Rifampin Resistant Staphylococcus epidermidis
Mirzaei, R., Alikhani, M. Y., Arciola, C. R., Sedighi, I., Irajian, G., Jamasbi, E., Yousefimashouf, R., & Bagheri, K. P. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.869650 · Cited by 27
Escalation of antimicrobial resistance among MRSA part 1: focus on global spread
Lynch, J. P., & Zhanel, G. G. (2022) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2154653 · Cited by 25
The Glycopeptide Antibiotics
Greule, A., & Cryle, M. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.14691-8 · Cited by 25
Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics
Chauhan, J., Cardinale, S., Fang, L., Huang, J., Kwasny, S. M., Pennington, M. R., Basi, K., diTargiani, R., Capacio, B. R., MacKerell, A. D., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164515 · Cited by 24
Detection of vancomycin nonsusceptible strains in clinical isolates of Staphylococcus aureus in northern Iran
Asadpour, L., & Ghazanfari, N. (2019) · International Microbiology · doi:10.1007/s10123-019-00063-7 · Cited by 24
Staphylococcus aureus Virulence Affected by an Alternative Nisin A Resistance Mechanism
Kawada‐Matsuo, M., Watanabe, A., Arii, K., Oogai, Y., Noguchi, K., Miyawaki, S., Hayashi, T., & Komatsuzawa, H. (2020) · Applied and Environmental Microbiology · doi:10.1128/aem.02923-19 · Cited by 24
In Vitro and In Vivo Antibacterial Activity of Gliotoxin Alone and in Combination with Antibiotics against Staphylococcus aureus
Esteban, P., Redrado, S., Comas, L., Domingo, M. P., Millán-Lou, M. I., Seral, C., Algarate, S., López, C., Rezusta, A., Pardo, J., et al. (2021) · Toxins · doi:10.3390/toxins13020085 · Cited by 24
High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S. aureus bacteraemia patients
Wang, J., Lai, C.-H., Lin, H.-H., Chen, W.-F., Shih, Y.-C., & Hung, C. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.07.010 · Cited by 24
Vancomycin dosing and monitoring 2 years after the guidelines
Lomaestro, B. M. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.46 · Cited by 24
Vancomycin tolerance in Gram‐positive cocci
Moscoso, M., Domenech, M., & Garcı́a, E. (2011) · Environmental Microbiology Reports · doi:10.1111/j.1758-2229.2011.00254.x · Cited by 24
Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus
Leonard, S. N., & Rolek, K. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks453 · Cited by 24
Vancomycin intermediate-Resistant Staphylococcus aureus (VISA) Isolated from a patient who never received Vancomycin treatment
Zhu, X., Liu, C., Gao, S., Lu, Y., Chen, Z., & Sun, Z. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.12.038 · Cited by 24
Heterogeneous vancomycin-intermediate susceptibility in a community-associated methicillin-resistant Staphylococcus aureus epidemic clone, in a case of Infective Endocarditis in Argentina
Sola, C., Lamberghini, R. O., Ciarlantini, M., Egea, A. L., González, P., Diaz, E. G., Huerta, V., Gonzalez, J., Corso, A. C., Vilaró, M., et al. (2011) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-10-15 · Cited by 24
Reduced Vancomycin Susceptibility of Methicillin-Susceptible Staphylococcus aureus Has No Significant Impact on Mortality but Results in an Increase in Complicated Infection
Sullivan, S. B., Austin, E. D., Stump, S., Mathema, B., Whittier, S., Lowy, F. D., & Uhlemann, A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00316-17 · Cited by 23
Staphylococcus aureus biofilms: an opportunistic pathogen with multidrug resistance
Silva‐Santana, G., Cabral-Oliveira, G. G., de Oliveira, D. R., Nogueira, B. A., Pereira-Ribeiro, P. M. A., & Mattos‐Guaraldi, A. L. (2020) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000223 · Cited by 25
Pet birds as potential reservoirs of virulent and antibiotic resistant zoonotic bacteria
Ahmed, H. A., Awad, N. F. S., El-Hamid, M. I. A., Shaker, A., Mohamed, R. E., & Elsohaby, I. (2020) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2020.101606 · Cited by 24
Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus
Tabuchi, F., Matsumoto, Y., Ishii, M., Tatsuno, K., Okazaki, M., Sato, T., Moriya, K., & Sekimizu, K. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.7 · Cited by 23
Predominance of ST5-II-t311 clone among healthcare-associated methicillin-resistant Staphylococcus aureus isolates recovered from Zhejiang, China
Wu, D., Wang, Z., Wang, H., Sun, L., Chen, Y., Ji, S., Shi, K., & Yu, Y. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.04.798 · Cited by 23
Attenuated total reflection: Fourier transform infrared spectroscopy for detection of heterogeneous vancomycin—intermediate Staphylococcus aureus
Wongthong, S., Tippayawat, P., Wongwattanakul, M., Poung-ngern, P., Wonglakorn, L., Chanawong, A., Heraud, P., & Lulitanond, A. (2020) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-019-2788-5 · Cited by 23
Treatment of Infections Caused By Antimicrobial-Resistant Gram-Positive Bacteria
Kinney, K. K. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181e99aa4 · Cited by 23
Emerging resistance inStaphylococcus epidermidisduring dalbavancin exposure: a case report andin vitroanalysis of isolates from prosthetic joint infections
Janabi, J. A., Tevell, S., Sieber, R. N., Stegger, M., & Söderquist, B. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac434 · Cited by 22
Evaluating the Translational Potential of Bacteriocins as an Alternative Treatment for Staphylococcus aureus Infections in Animals and Humans
Heinzinger, L. R., Pugh, A. R., Wagner, J. A., & Otto, M. J. (2023) · Antibiotics · doi:10.3390/antibiotics12081256 · Cited by 24
Intradermal Immunization with Wall Teichoic Acid (WTA) Elicits and Augments an Anti-WTA IgG Response that Protects Mice from Methicillin-Resistant Staphylococcus aureus Infection Independent of Mannose-Binding Lectin Status
Takahashi, K., Kurokawa, K., Moyo, P., Jung, D.-J., An, J.-H., Chigweshe, L., Paul, E., & Lee, B. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069739 · Cited by 22
High Prevalence of Isolates with Reduced Glycopeptide Susceptibility in Persistent or Recurrent Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus
Uçkay, İ., Bernard, L., Buzzi, M., Harbarth, S., François, P., Huggler, E., Ferry, T., Schrenzel, J., Renzoni, A., Vaudaux, P. E., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05808-11 · Cited by 22
Clinical and Microbiologic Analysis of the Risk Factors for Mortality in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bacteremia
Chong, Y. P., Park, K., Kim, E. S., Kim, M., Kim, S., Lee, S., Choi, S., Jeong, J., Woo, J. H., & Kim, Y. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04765-14 · Cited by 22
Development and Control of Biofilms in Diabetic Foot Infections: A Narrative Review
Ray, H., Weis, C., Nwaeze, C., Zhou, V., Basu, P., & Mitra, A. (2025) · Acta Microbiologica Hellenica · doi:10.3390/amh70010009 · Cited by 21
The occurrence and dissemination of methicillin and vancomycin-resistant Staphylococcus in samples from patients and health professionals of a university hospital in Recife, State of Pernambuco, Brazil
Rabelo, M. A., Neto, A. M. B., Loibman, S. O., Lima, J. L. D. C., Ferreira, E. L., Leal, N. C., & Maciel, M. A. V. (2014) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0071-2014 · Cited by 21
Epidemiology of Staphylococcus aureus Non-Susceptible to Vancomycin in South Asia
Ejaz, M., Syed, M. A., Jackson, C. R., Sharif, M., & Faryal, R. (2023) · Antibiotics · doi:10.3390/antibiotics12060972 · Cited by 21
A Molecular Switch‐Integrated Nanoplatform Enables Photo‐Unlocked Antibacterial Drug Delivery for Synergistic Abscess Therapy
Yan, Y., Liu, Y., Li, J., Li, Y., Wu, H., Li, H., Ma, X., Tang, Y., Tong, Y., Yi, K., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301157 · Cited by 21
Increasing Trend of Heterogeneous Vancomycin Intermediate Staphylococcus aureus in a Tertiary Care Center of Northern India
Singh, A. K., Prasad, K. N., Misra, R., Rahman, M., Singh, S. K., Rai, R. P., Tripathi, A., & Srivastava, J. K. (2015) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0004 · Cited by 21
Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now?
Edwards, B., Andini, R., Esposito, S., Grossi, P., Lew, D., Mazzei, T., Novelli, A., Soriano, À., & Gould, I. M. (2014) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2014.03.009 · Cited by 21
Vancomycin in the treatment of meticillin-resistant Staphylococcus aureus (MRSA) infection: End of an era?
Bal, A. M., Garau, J., Gould, I. M., Liao, C., Mazzei, T., Nimmo, G. R., Soriano, À., Stefani, S., & Tenover, F. C. (2013) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2013.01.002 · Cited by 21
Production of capsular polysaccharide does not influence Staphylococcus aureusvancomycin susceptibility
Jansen, A., Szekat, C., Schröder, W., Wolz, C., Goerke, C., Lee, J. C., Türck, M., & Bierbaum, G. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-65 · Cited by 21

Authors: Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L.
Affiliations: The University of Melbourne (AU)
Monash University (AU)
ORCID: Howden, Benjamin P.
Johnson, Paul D. R.
Stinear, Timothy P.
Venue: Clinical Microbiology Reviews
Publisher: American Society for Microbiology
Published: 2010-01
Volume: 23
Issue: 1
Pages: 99-139
ISSN: 0893-8512 (ISSN-L)
1098-6618
DOI: 10.1128/cmr.00042-09
PMC: PMC2806658
OpenAlex: W2126915534
Cited by: 962
References: 406
Citations by year: 2026: 42 · 2025: 41 · 2024: 48 · 2023: 58 · 2022: 45 · 2021: 52 · 2020: 49 · 2019: 60 · 2018: 54 · 2017: 51 · 2016: 63 · 2015: 83 · 2014: 69 · 2013: 88 · 2012: 72
FWCI: 9.15
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Clinical Microbiology Reviews (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Keywords: vancomycin-intermediate Staphylococcus aureus, heterogeneous vancomycin-intermediate Staphylococcus aureus, reduced vancomycin susceptibility, glycopeptide resistance, cell wall thickening, agr gene, vancomycin susceptibility testing, treatment failure, host-pathogen interaction
MeSH terms: Anti-Bacterial Agents, Humans, Microbial Sensitivity Tests, Staphylococcal Infections, Staphylococcus aureus, Vancomycin, Treatment Outcome, Vancomycin Resistance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks